Clinical Trials Related to Bristol-Myers Squibb

Related studies linked through entity extraction aliases.

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

Status: RECRUITING
Phase: N/A

Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis

Status: COMPLETED
Phase: PHASE4

Neoadjuvant KRAS G12C Directed Therapy With Adagrasib (MRTX849) With or Without Nivolumab

Status: WITHDRAWN
Phase: PHASE2

Oral AHR Antagonist in Combination With Nivolumab in Patients With PD-1 Resistant Metastatic or Recurrent Head and Neck Cancer

Status: WITHDRAWN
Phase: PHASE1

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy

Status: TERMINATED
Phase: PHASE2/PHASE3

A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2/PHASE3

A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Sulfasalazine

Status: COMPLETED
Phase: PHASE1

A Study of VAC85135, a Neoantigen Vaccine Regimen, Concurrently Administered With Ipilimumab for the Treatment of Myeloproliferative Neoplasms

Status: COMPLETED
Phase: PHASE1

COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

A Study of Treatment Patterns and Outcomes in Participants With Stage IIIA Melanoma Receiving Adjuvant Systemic Therapy

Status: COMPLETED
Phase: N/A

Treatment Patterns and Outcomes in Participants With Advanced Melanoma in Germany Using a German Database

Status: COMPLETED
Phase: N/A

A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database

Status: COMPLETED
Phase: N/A

A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate

Status: COMPLETED
Phase: N/A

A Study of Overall Survival in Participants With Metastatic Colorectal Cancer (mCRC)

Status: COMPLETED
Phase: N/A

A Phase 2 Clinical Trial of Neoadjuvant Relatlimab and Nivolumab in High Risk, Clinical Stage II Cutaneous Melanoma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

A Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy

Status: COMPLETED
Phase: PHASE3

A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register

Status: COMPLETED
Phase: N/A

An Efficacy and Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy in Chinese Participants With Acute Myeloid Leukemia in Complete Remission

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

A Study to Evaluate the Drug Levels of BMS-986166 in Healthy Male Participants

Status: COMPLETED
Phase: PHASE1

A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors

Status: COMPLETED
Phase: PHASE1/PHASE2